MAM
CBST

Martingale Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Martingale Asset Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-13,312
Closed -$643K – 1079
2013
Q2 		$643K Buy
+13,312
New +$654K 0.02% 674

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Martingale Asset Management's CBST Position: Q3 2013 in Review

Martingale Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2013, closing a stake of 13,312 shares — an estimated $643K sold.

Martingale Asset Management first reported a position in CBST in Q2 2013 and held it in 1 quarter. The position peaked at $643K in Q2 2013. 271 funds tracked by Wall St. Rank hold CBST as of Q3 2013.

  • Martingale Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Martingale Asset Management sold 13,312 CUBIST PHARMACEUTICALS INC shares in Q3 2013, an estimated $643K.
  • Martingale Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Martingale Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $643K in Q2 2013.
  • 271 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2013.

Based on Martingale Asset Management's 13F filing for Q3 2013, filed 13 Nov 2013.